31st European Meeting on Hypertension and Cardiovascular Protection – Athens, Greece
Megaron Athens International Conference Center Leoforos Vasilissis Sofias and, Petrou Kokkali 1, AthensThe 31st Scientific Meeting of the European Society of Hypertension (ESH) on “Hypertension and Cardiovascular Protection” will be held in Athens, June 17-20, 2022. The 2022 Annual Athens Meeting is the first ESH Hybrid Meeting and provides the possibility of onsite as well as online participation, aiming to meet the needs of all colleagues from […]
Edoxaban: ENGAGEing in Individualisation of DOACs – ISCP Webinar
Online WebinarDirect oral anticoagulants (DOACs) have revolutionised the treatment of venous thromboembolism and atrial fibrillation. By the time edoxaban was approved in 2015, healthcare providers already had a few years of experience with using dabigatran, rivaroxaban and apixaban and determining which is preferred based on patient characteristics. This webinar will review the use of edoxaban, with […]
ESC Congress 2022 – Barcelona, Spain
We are delighted to announce that ESC Congress will welcome you back from 26 to 29 August 2022 - onsite in Barcelona and online, around the globe. Scientific Programme ESC Congress covers all topics within cardiovascular medicine; presenting and discussing the latest scientific findings and providing in-depth clinical teaching and education. The congress will emphasise […]
ACC with 13th Emirates Cardiac Society Congress 2022 – Dubai, UAE
The American College of Cardiology and Emirates Cardiac Society invite you to join us for an innovative educational experience that will strengthen your everyday practice. ACC Middle East 2022 Together With 13th Emirates Cardiac Society Congress is designed to deliver an engaging forum to critically examine evidence-based strategies as well as contemporary best practices and clinical decision-making […]
VIII ESVM Annual Congress 2022 – Stockholm, Sweden
Stockholm City Conference Centre Barnhusgatan 12-14, StockholmWelcome to the 8th annual Congress of the European Society of Vascular Medicine (ESVM) Congress in Stockholm, October 6–8, 2022. The 2022 congress in Stockholm will be organized by the Swedish Society of Hypertension, Stroke, and Vascular Medicine under the auspices of the European Society of Vascular Medicine. It will be held at Stockholm City […]
Brazilian Congress of Cardiology with WCC 2022 – Rio de Janeiro, Brazil
In 2022, Rio de Janeiro will be the stage of one of the largest and most important cardiology events of the year: the 77th Brazilian Congress of Cardiology together with the World Congress of Cardiology, organized by the Brazilian Society of Cardiology in partnership with the World Heart Federation.
Novel Pharmacological Treatments for the Prevention of Cardiovascular Events
Online WebinarNovel Pharmacological Treatments for the Prevention of Cardiovascular Events Which agents to use and which patients benefit from the newer interventions? OVERVIEW This webinar focuses on the use of novel pharmacological treatment strategies aimed at improving cardiovascular outcomes in medium to high-risk patients. The focus will be on newer lipid lowering agents and novel antidiabetic […]
Clopidogrel or Ticagrelor: Why, When, for Whom?
Online WebinarDual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is the cornerstone of the management of acute coronary syndromes. Despite its proven benefits, the choice of P2Y12 inhibitors remains to be debated over the decades because of the differences in efficacy and safety profiles among these agents. In this 60-minute session by the […]
ACC.23/WCC
The American College of Cardiology joins the World Heart Federation to host ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, LA, March 4 – 6, 2023. Learn more and register today: https://accscientificsession.acc.org/
Nebivolol: No limb pain?
Online WebinarBeta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the newer generation of beta-blockers and greater cardio-selectivity. One of the challenges all clinicians face is to manage the choice of numerous beta-blockers and in particular […]